Skip to content

Observation on the sensitizing effect and mechanism of acupuncture at Hegu point on transcranial magnetic stimulation in the treatment of peripheral facial paralysis based on "Facial Oral Hegu Shu"

Observation on the sensitizing effect and mechanism of acupuncture at Hegu point on transcranial magnetic stimulation in the treatment of peripheral facial paralysis based on "Facial Oral Hegu Shu"

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000296
Enrollment
Unknown
Registered
2024-08-24
Start date
2024-08-16
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral facial nerve palsy

Interventions

Observation group for patients with peripheral facial nerve palsy:Acupuncture and electrical pulse stimulation were performed on the Hegu point of patients with peripheral facial paralysis, and magnet
healthy volunteer observation group:Acupuncture and electrical pulse stimulation were performed on the Hegu point of healthy volunteers and magnetic stimulation evoked potentials were detected before

Sponsors

The Second Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: This experiment is divided into two parts: a study on healthy subjects and a study on patients with peripheral facial nerve palsy. 1. Inclusion criteria for volunteers in the healthy volunteer group (1) Age 18 to 35 years old, no gender limit; (2) Right-handed; (3) Have good health in the past and can tolerate acupuncture and transcranial magnetic stimulation; (4) No physical abnormalities (such as fever, cough, etc.) during the trial period; (5) Voluntarily participate in this study, fully understand and sign the informed consent form. Cases must all meet the above five criteria to be included. 2. Inclusion criteria for patients with peripheral facial paralysis: (1) Meet the diagnostic standards of traditional Chinese medicine and Western medicine for peripheral facial paralysis; (2) The patient has no contraindications to the transcranial magnetism and acupuncture used; (3) Diagnosed for the first time and unilaterally affected; (4) Age 18 to 65 years old, no gender limit; (5) Voluntarily participate in this study, fully understand and sign the informed consent form. Cases must all meet the above five criteria to be included.

Exclusion criteria

Exclusion criteria: This experiment is divided into two parts: a study on healthy subjects and a study on patients with peripheral facial nerve palsy. 1. Exclusion criteria for volunteers in the healthy volunteer group (1) Those with a history of craniocerebral trauma or surgery; (2) Patients with neurological diseases such as Parkinson's disease and dementia; (3) Patients with hypertension, diabetes and major heart, liver, kidney and other organ diseases; (4) Those who have pacemakers, stents and other metal objects in their bodies; (5) Those who are afraid or unable to undergo acupuncture, TMS or peripheral nerve electrical stimulation for other reasons; (6) Pregnant person. (7) Patients with severe cerebrovascular, malignant tumors, blood and mental system diseases; (8) Clinical trial participants who also participated in other clinical trials; Note: Patients who meet any of the above conditions should be excluded. 2. 2. Exclusion criteria for peripheral facial paralysis patient group: (1) Those with a history of craniocerebral trauma or surgery; (2) Patients with neurological diseases such as Parkinson's disease and dementia; (3) Patients with hypertension, diabetes and major heart, liver, kidney and other organ diseases; (4) Those who have pacemakers, stents and other metal objects in their bodies; (5) Those who are afraid or unable to undergo acupuncture, TMS or peripheral nerve electrical stimulation for other reasons; (6) Pregnant, perinatal and lactating women; (7) Patients with severe cerebrovascular, malignant tumors, blood and mental system diseases; (8) Clinical trial participants who also participated in other clinical trials; Note: Patients who meet any of the above conditions should be excluded.

Design outcomes

Primary

MeasureTime frame
transcranial magnetic stimulation evoked action potentials;

Secondary

MeasureTime frame
House-Brackmann scale score;

Countries

China

Contacts

Public ContactChen Jun

Shaanxi University of Traditional Chinese Medicine

584432697@qq.com15991032768

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026